Linda Mussallem is the co-founder of the Mussallem CHD Alliance and the Linda and Mike Mussallem Foundation, and a lifelong advocate for integrative health, inclusive design, and whole-person care. Through her philanthropic leadership, she has advanced health equity and community-based wellness initiatives, with a particular focus on underserved and historically excluded populations, including individuals with Down syndrome. Linda serves on the Advisory Board of the Susan Samueli Integrative Health Institute and co-founded the George and Bob Fund, which has contributed more than $25 million to programs that elevate dignity, access, and quality of life. Her work bridges healthcare advocacy, design, and strategic philanthropy to create environments where people can thrive.

Mike Mussallem is the co-founder of the Mussallem CHD Alliance, the Linda and Mike Mussallem Foundation, and the former Chairman and CEO of Edwards Lifesciences. During more than two decades of leadership, he helped transform structural heart care and establish Edwards as a global leader in patient-centered medical technology, while also launching the Edwards Lifesciences Foundation. Together with his wife Linda, Mike has long supported health equity, Down syndrome advocacy, and whole-person care through strategic philanthropy. Their joint efforts include co-founding the George and Bob Fund to drive innovation, access, and system-level impact for people living with Down syndrome.

Orin Herskowitz is the President of the Mussallem CHD Alliance. Prior to joining the Alliance, he served as Senior Vice President of Applied Innovation at Columbia University, where he led initiatives spanning innovation, entrepreneurship, technology transfer, and science-based economic development. Orin has been deeply engaged in regional and national innovation efforts, including service with the Center for American Entrepreneurship and the U.S. Department of Commerce’s National Advisory Council on Innovation and Entrepreneurship. He has also advised organizations such as the National Science Foundation, ARPA-H, and Schmidt Futures.